跳至主要内容
临床试验/TCTR20141209001
TCTR20141209001已完成未知

Effects of Lactobacillus delbrueckii and Streptococcus thermophillus on tailored triple therapy forHelicobacter pylori eradication: A prospective randomized controlled clinical trial

institute of reserch and development, Suranaree University of Technology0 个研究点目标入组 300 人开始时间: 2014年12月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • Helicobacter pylori associated gastritis

排除标准

  • age below 18 or above 70 years, previous Helicobacter pylori eradication treatment before previous 2 months, gastric ulcer or duodenal ulcer, suspected or confirmed malignancy on endoscopy, significant medical illnesses and history of previous gastric surgery, pregnant or lactating women, and the use of antimicrobials or gastrointestinal medications like PPIs or bismuth compounds within the previous 2 months, refuse yogurt due to underlying disease such as DM ,history of drug allergy in first line therapy

研究者

发起方
institute of reserch and development, Suranaree University of Technology

相似试验